Skip to main content
. 2022 Oct 28;119(44):e2211194119. doi: 10.1073/pnas.2211194119

Fig. 6.

Fig. 6.

Detection and validation of a private somatic intronic deletion of ITPKB in a lymphoma patient. (A) Detection of a somatic intronic 59-nt deletion of ITPKB that removed all three BP sites in intron-3. (B) RNA-seq reads alignment on ITPKB that showed intronic retention in the lymphoma patient carrying this variant but not in the patients without this variant. (C) Sashimi plot from the RNA-seq data.

HHS Vulnerability Disclosure